Physician profile
Toddrick Lamont Tookes
NPI 1780976373
$6,597.79
in general payments reported to CMS, 2019-2025
50 companies · $1,721 in 2025
The $1,721 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.46 · 2020: $258 · 2021: $1,230 · 2022: $1,187 · 2023: $1,134 · 2024: $1,052 · 2025: $1,721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,906.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,853.75 | 2021-2025 | Puraply, Via Matrix, Novachor |
| Janssen Pharmaceuticals, INC | $401.79 | 2021-2023 | Xarelto |
| Lilly USA, LLC | $321.41 | 2022-2024 | Jardiance, Emgality, Mounjaro |
| Novo Nordisk INC | $306.21 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $229.17 | 2020-2025 | Evenity, Otezla, Repatha |
| Advanced Medical Administration | $224.09 | 2025 | Amniograft |
| Esperion Therapeutics, INC. | $203.69 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $189.48 | 2022-2025 | |
| Amarin Pharma, INC. | $136.64 | 2020-2021 | |
| Xeris Pharmaceuticals, INC. | $133.26 | 2022-2024 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.94 | 2021-2024 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Smith+Nephew, INC. | $98.23 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $85.67 | 2021-2022 | |
| Abbvie INC. | $83.67 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $71.66 | 2021 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $67.99 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $67.64 | 2021-2025 | Gardasil 9, Capvaxive |
| Takeda Pharmaceuticals U.S.A., INC. | $64.28 | 2020-2021 | |
| Glaxosmithkline, LLC. | $60.97 | 2022-2025 | Arexvy, Trelegy Ellipta |
| Pfizer INC. | $60.87 | 2021-2023 | |
| Vertex Pharmaceuticals Incorporated | $58.34 | 2024-2025 | |
| Kci USA, INC. | $53.07 | 2020 | |
| Baxter Healthcare | $51.32 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Exact Sciences Corporation | $46.90 | 2024-2025 | Cologuard Collection Kit |
| Mimedx Group, INC. | $43.49 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $40.76 | 2022-2025 | Zoryve |
| Astrazeneca Pharmaceuticals Lp | $37.65 | 2024 | Lokelma |
| Teva Pharmaceuticals USA, INC. | $37.60 | 2023-2025 | Austedo Xr, Austedo Xr |
| Next Science LLC | $35.66 | 2023 | Blastx, Xperience, Surgx |
| Triad Life Sciences INC. | $32.12 | 2022 | |
| Viatris Specialty LLC | $29.73 | 2025 | Yupelri |
| Daiichi Sankyo INC. | $29.64 | 2020-2021 | |
| Solventum Corporation | $29.36 | 2025 | Activ.A.C., Snap |
| Insulet Corporation | $27.89 | 2020-2021 | |
| Surgenex LLC | $24.44 | 2025 | Renograft, Surgraft, Ardeograft |
| Echosens North America, INC. | $24.43 | 2024 | Fibroscan |
| Sumitomo Pharma America, INC. | $22.84 | 2025 | Gemtesa |
| Alnylam Pharmaceuticals INC. | $22.79 | 2025 | Amvuttra |
| Seqirus USA INC | $21.12 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Dexcom, INC. | $20.50 | 2023 | Dexcom G6 Transmitter |
| Actelion Pharmaceuticals US, INC. | $19.79 | 2025 | Uptravi, Opsumit |
| Biohaven Pharmaceutical Holding Company Ltd. | $18.30 | 2022 | |
| Nevro Corp. | $15.30 | 2023 | Senza |
| Azurity Pharmaceuticals, INC. | $14.29 | 2023 | Edarbi |
| Djo, LLC | $14.16 | 2023 | Cmf |
| Paratek Pharmaceuticals, INC. | $13.54 | 2025 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $12.83 | 2023 | Eliquis |
| Electromed, INC. | $12.82 | 2023 | Smartvest |
| Integra Lifesciences Corporation | $12.51 | 2020 | |
| Tactile Systems Technology INC | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Toddrick Tookes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.